天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 24072-75-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 24072-75-1
Chemical Structure| 24072-75-1
Structure of 24072-75-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 24072-75-1 ]

Related Doc. of [ 24072-75-1 ]

Alternatived Products of [ 24072-75-1 ]
Product Citations

Product Details of [ 24072-75-1 ]

CAS No. :24072-75-1 MDL No. :MFCD00053558
Formula : C7H4Cl2N2S Boiling Point : No data available
Linear Structure Formula :- InChI Key :GHKHTBMTSUEBJD-UHFFFAOYSA-N
M.W : 219.09 Pubchem ID :32206
Synonyms :

Calculated chemistry of [ 24072-75-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 54.04
TPSA : 67.15 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.97
Log Po/w (XLOGP3) : 3.29
Log Po/w (WLOGP) : 3.19
Log Po/w (MLOGP) : 2.44
Log Po/w (SILICOS-IT) : 3.69
Consensus Log Po/w : 2.91

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.83
Solubility : 0.0327 mg/ml ; 0.000149 mol/l
Class : Soluble
Log S (Ali) : -4.38
Solubility : 0.00923 mg/ml ; 0.0000421 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -3.85
Solubility : 0.0309 mg/ml ; 0.000141 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.21

Safety of [ 24072-75-1 ]

Signal Word:Warning Class:
Precautionary Statements:P280-P305+P351+P338 UN#:
Hazard Statements:H317-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 24072-75-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 24072-75-1 ]

[ 24072-75-1 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 333-20-0 ]
  • [ 95-76-1 ]
  • [ 24072-75-1 ]
YieldReaction ConditionsOperation in experiment
19% at 0 - 15℃; for 16 h; j00320j To a mixture of 3,4-dichloroaniline (10 g, 62 mmol) and potassium thiocyanate (48 g, 0.49 mol) in acetic acid (160 mL) at 0 °C was added slowly with constant stirring a solution of liquidbromine (31 g, 0.19 mol) in acetic acid (160 mL). The temperature was maintained at 0 °C throughout the addition. The solution was stirred for 2 hours at 0°C and 14 hours at 15 °C, then diluted with water (100 mL), adjusted to pH 78 with ammonium hydroxide and extracted with ethyl acetate (3 x 50 mL). The combined organic layers were washed with brine (3 x 300 mL) and concentrated in vacuo. The residue was purified by prep-HPLC [Instmment: GX-B; Column: GEMNI 250 x 50 mm, particle size: 10 .im; Mobile phase: 25-50percent acetonitrile in H20 (add 0.1percent TFA, v/v)j to give compound B- 24 (2.6 g, 19percent yield) as a white solid. LCMS (J): tR=0.694 mi (ES) m/z (M+H)219.0. ‘H-NMR (CD3OD, 400 MHz): 7.89 (s, 1H), 7.55 (s, 1H).
Reference: [1] Patent: WO2017/69980, 2017, A1, . Location in patent: Paragraph 00319; 00320
[2] Bioorganic Chemistry, 2016, vol. 67, p. 130 - 138
  • 2
  • [ 19250-09-0 ]
  • [ 24072-75-1 ]
  • [ 25150-27-0 ]
Reference: [1] Patent: WO2016/42172, 2016, A1, . Location in patent: Page/Page column 78; 79
  • 3
  • [ 1147550-11-5 ]
  • [ 95-76-1 ]
  • [ 24072-75-1 ]
  • [ 25150-27-0 ]
Reference: [1] Heterocyclic Communications, 2002, vol. 8, # 3, p. 275 - 280
  • 4
  • [ 19250-09-0 ]
  • [ 24072-75-1 ]
Reference: [1] Medicinal Chemistry Research, 2013, vol. 22, # 9, p. 4211 - 4222
  • 5
  • [ 95-76-1 ]
  • [ 24072-75-1 ]
Reference: [1] Medicinal Chemistry Research, 2013, vol. 22, # 9, p. 4211 - 4222
  • 6
  • [ 33240-95-8 ]
  • [ 24072-75-1 ]
Reference: [1] Medicinal Chemistry Research, 2013, vol. 22, # 9, p. 4211 - 4222
  • 7
  • [ 333-20-0 ]
  • [ 95-76-1 ]
  • [ 24072-75-1 ]
  • [ 25150-27-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1971, vol. 8, p. 309 - 310
  • 8
  • [ 95-76-1 ]
  • [ 24072-75-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 2010, vol. 45, # 9, p. 4293 - 4299
[2] Archiv der Pharmazie, 2010, vol. 343, # 11-12, p. 692 - 699
  • 9
  • [ 1147550-11-5 ]
  • [ 95-76-1 ]
  • [ 24072-75-1 ]
Reference: [1] Journal of Enzyme Inhibition and Medicinal Chemistry, 2011, vol. 26, # 4, p. 527 - 534
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;